Our previous study revealed that TGR5 can inhibit IκBα phosphorylation and then the nuclear translocation of p65 through enhancing β-arrestin2 interaction with IκBα, resulting in antagonizing the NF-κB signaling pathway in liver cancer cells [7]. Here, GPBAR1 is linked to liver cancer.